Drug Discovery

Sitting Down With… Paul Peter Tak, President and CEO at Kintai Therapeutics.

How far along is the pharmaceutical industry in its journey with 3D cell culture technologies?

A new analytical technique could help in the production of purer pharmaceuticals.

Using green light, a titanium catalyst could be a non-hazardous alternative to commonly used metal-based catalysts.

Researchers are investigating the therapeutic value of immunotherapies for treating infectious diseases.

A gene therapy could help prevent the symptoms of glaucoma.

Inhaled administration has the potential to bring benefits to patients – and commercial success to businesses – across a number of therapeutic spaces.

A repurposed drug could help improve immunotherapy response rates.

How can artificial intelligence and deep-learning platforms be used to combat malaria?

Can we reverse the effect of the ageing process on the immune system?